Skip to content
中文产业新闻评分60Chinese source

BMS 艾泊度胺胶囊获 NMPA 附条件批准,联合达雷妥尤单抗和地塞米松治疗多发性骨髓瘤

刚刚,一款重磅新药在中国获批上市!

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.